Quarter Financials

TG Therapeutics, Inc. (TGTX)

$25.92

-0.57 (-2.15%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1
Net Income -53-36-41-69-93-86-78-91
Dividend Paid --------
Retained Earnings -1,527-1,474-1,438-1,398-1,329-1,235-1,150-1,071

PPE Schedule

Year 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1
Capital Expenditure ----0-0-0-0-0
Net PPE 99111111111212

Intangible and Goodwill Schedule

Year 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1
New Purchases -17-14-12-12-57-15--
Intangible and Goodwill 11111111